<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04086862</url>
  </required_header>
  <id_info>
    <org_study_id>Study00001683</org_study_id>
    <nct_id>NCT04086862</nct_id>
  </id_info>
  <brief_title>Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Comparison of 1 Megahertz Versus 3 Megahertz</brief_title>
  <official_title>Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Comparison of 1 Megahertz Versus 3 Megahertz</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State University of New York at Buffalo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>State University of New York at Buffalo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Temporomandibular disorders (TMD) are a group of musculoskeletal and neuromuscular conditions
      that involve the temporomandibular joints, the masticatory muscles, and all associated
      tissues. These disorders are characterized by regional pain and limitation of mandibular
      range of motion. Pain-related TMD affects approximately 5% to 12% of the population and can
      affect individual's quality of life. The incidence is about 4 percent. Therapeutic ultrasound
      is a type of physical therapy that delivers energy via propagation of ultrasonic waves. One
      gap in knowledge is whether 1 megahertz (MHz) treating frequency has the same efficacy as
      treating with 3 MHz. This research proposes to test that.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      See brief summary.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 24, 2019</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Subjects will be randomized to double-blind treatment with 1 MHz or 3 MHz therapeutic ultrasound.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>The frequency setting on the ultrasound machine will be set and known only to the principal investigator.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in masseter pain by visual analog pain scale.</measure>
    <time_frame>Baseline to fifth week.</time_frame>
    <description>Reduction in masseter pain as measured on a visual analog scale (VAS). The VAS runs from 0 (no pain at all) to 100 (worst pain imaginable).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction in masseter pain by pressure pain threshold.</measure>
    <time_frame>Baseline to fifth week.</time_frame>
    <description>Reduction in masseter pain as measured with the pressure pain threshold (VAS). The VAS runs from 0 (no pain at all) to 100 (worst pain imaginable)..</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Adult Females</condition>
  <condition>Bilateral Masseter Myalgia</condition>
  <arm_group>
    <arm_group_label>The 1 MHz group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The 1 MHz group will receive therapeutic ultrasound at the 1 MHz setting.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>The 3 MHz group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The 3 MHz group will receive therapeutic ultrasound at the 3 MHz setting.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Therapeutic ultrasound</intervention_name>
    <description>A commercially available ultrasound machine will provide 5 minutes of ultrasound at 0.4 watt/cm^2 and 100% duty cycle sequentially to each masseter muscle.</description>
    <arm_group_label>The 1 MHz group</arm_group_label>
    <arm_group_label>The 3 MHz group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult females

          -  Bilateral myalgia based on Diagnostic Criteria for TMD (DC-TMD) criteria

          -  An average pain of 5 or more on a 0 to 10 scale over the last 30 days.

        Exclusion Criteria:

          -  A history or diagnosis of systemic musculoskeletal disorders or rheumatologic diseases
             (e.g. fibromyalgia, muscular atrophy).

          -  Certain conditions such as neoplasms or fractures.

          -  Neuropathies or neurological disorders.

          -  Currently taking muscle relaxants or analgesics.

          -  Undergone any form of physical therapy within the last 60 days.

          -  Severe bruxism requiring mouth-guard treatment.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>W. D. McCall, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>State University of New York at Buffalo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>W. D. McCall, Ph.D.</last_name>
    <phone>7168293559</phone>
    <email>wdmccall@buffalo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yoly M Gonzalez, M.S.</last_name>
    <phone>716-829-3551</phone>
    <email>ymg@buffalo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>School of Dental Medicine</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoly Gonzalez, DDS, MS</last_name>
      <phone>716-829-3559</phone>
      <email>ymg@buffalo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>September 10, 2019</study_first_submitted>
  <study_first_submitted_qc>September 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 12, 2019</study_first_posted>
  <last_update_submitted>March 17, 2020</last_update_submitted>
  <last_update_submitted_qc>March 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>State University of New York at Buffalo</investigator_affiliation>
    <investigator_full_name>W.D.McCall, Jr.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>temporomandibular disorders</keyword>
  <keyword>masseter myalgia</keyword>
  <keyword>adult female</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myalgia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>De-identified data may be shared after analysis completed.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

